Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02188160Phase 2Completed
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Dry Eye SyndromesKeratoconjunctivitis Sicca
Principalinvestigator

Research Network

Collaboration Network

18 collaborators·51 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

North Valley Eye Medical Group

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Marc Abrams, MD

Abrams Eye Center

Moderately Similar
2 trials

Shared therapeutic areas:

BlepharitisDry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 2 trials
Similarity Score38%

Kenneth Sall, MD

Sall Research Medical Center

Moderately Similar
3 trials

Shared therapeutic areas:

Dry Eye SyndromesBlepharitisKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 2 trials
Similarity Score38%

Jodi Luchs, MD

South Shore Eye Center

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Gregg Berdy, MD

Ophthalmology Associates

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Mark Milner, MD

Eye Center of Southern CT, P.C.

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

David Evans, OD

Total Eye Care, PA

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Joseph Martel, MD

Martel Eye Medical Group

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Michael Korenfeld, MD

Ecomprehensive Eye Care, Ltd / Vision Research Institute LLC

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Kathy Kelley, OD

Price Vision Group

Related
2 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Jeffrey Whitsett, MD

Whitsett Vision Group

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02188160Phase 2PrincipalInvestigator

Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease

Dry Eye SyndromesKeratoconjunctivitis Sicca
Completed
NCT02218489Phase 2PrincipalInvestigator

Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease

Blepharitis
Completed

All 2 trials loaded